Enzolytics Inc (ENZC)

[poncewaves]

? Rockwall-based BioClonetics, a biotech startup working on the first cure for HIV using monoclonal antibodies, is merging with a Plano company to accelerate and expand drug development and testing. Drug development company Enzolytics has executed a non-binding letter of intent to merge with the startup co-founded by brothers Charles Cotropia and Joseph Cotropia in 2009. Harry Zhabilov, CEO of Enzolytics, said combining the “two companies’ proprietary technologies and products is a once in a lifetime opportunity that should benefit both of our organizations letting us achieve more together than we could apart.”